The differential expression of Src-regulated CRPC signature genes and of FOXO1, TOP2B and ZNF217 correlates with earlier metastatic onset and poorer clinical outcomes in PC patients, underlying the notion that Src is a critical driver of AR-dependent CRPC progression. The gene discussed is FOXO1; the disease is pachyonychia congenita.